Senomyx Inc. (SNMX) Stock Price Down 2.4%
Shares of Senomyx Inc. (NASDAQ:SNMX) traded down 2.4% during mid-day trading on Monday . The stock traded as low as $2.36 and last traded at $2.41, with a volume of 78,843 shares. The stock had previously closed at $2.47.
Separately, Zacks Investment Research cut Senomyx from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th.
The firm’s market cap is $111.00 million. The stock has a 50 day moving average of $2.95 and a 200-day moving average of $2.90.
Senomyx (NASDAQ:SNMX) last announced its quarterly earnings results on Thursday, April 28th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The company earned $6.30 million during the quarter, compared to analysts’ expectations of $5.78 million. During the same quarter in the previous year, the firm earned ($0.11) EPS. The firm’s revenue for the quarter was up 26.0% compared to the same quarter last year. Equities analysts predict that Senomyx Inc. will post ($0.25) EPS for the current fiscal year.
A hedge fund recently raised its stake in Senomyx stock. Turner Investments L.P. increased its stake in Senomyx Inc. (NASDAQ:SNMX) by 10.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 345,000 shares of the company’s stock after buying an additional 33,000 shares during the period. Turner Investments L.P. owned about 0.78% of Senomyx worth $1,301,000 at the end of the most recent quarter.
Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.